Luca Lanino

A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study

G. Castellani, F. Solé, T. Haferlach, 2022, The Lancet. Haematology.

Case Report: Atypical Manifestations Associated With FOXP3 Mutations. The “Fil Rouge” of Treg Between IPEX Features and Other Clinical Entities?

E. Fiaccadori, G. Ghiggeri, G. Caridi, 2022, Frontiers in Immunology.

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.

G. Castellani, A. Viale, M. Cazzola, 2022, NEJM evidence.

Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden

M. Gobbi, R. Fanin, N. Colombo, 2020, Cancers.

Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities

P. Esposito, A. Alogna, A. Faragli, 2021, Kidney and Blood Pressure Research.

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

G. Castellani, F. Solé, N. Bolli, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts

P. Pasini, I. Naldi, S. Paolini, 2023, American journal of hematology.

Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis

M. Tormo, M. Díaz-Beyá, L. Zamora, 2024, Frontiers in oncology.

MOSAIC: An Artificial Intelligence–Based Framework for Multimodal Analysis, Classification, and Personalized Prognostic Assessment in Rare Cancers

Pierandrea Morandini, V. Savevski, I. Prada-Luengo, 2024, JCO clinical cancer informatics.

Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation

M. Díez-Campelo, R. Komrokji, C. Tentori, 2024, JCO clinical cancer informatics.

Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology

A. Krogh, G. Castellani, T. Haferlach, 2023, JCO clinical cancer informatics.